Updated:
Longevity Venture Partners
Longevity Venture Partners is an American early-stage venture capital fund specializing in the Silvertech, Healthcare and Wellness sectors. CommuniCare Family...
Longevity Venture Partners
Longevity Venture Partners is an American early-stage venture capital fund specializing in the Silvertech, Healthcare and Wellness sectors. CommuniCare Family of Companies is Longevity’s parent company and a major U.S. health care enterprise with more than 90 facilities in the U.S.
General information
Firm type
Venture Capital
Year founded
2020
Location
Region
North America
Country
United States
City
Pikesville
Corporate office
Baltimore, MD, United States
Sector focus
Frequently asked questions
What is Longevity Venture Partners' core investment thesis?
The firm concentrates exclusively on extending healthy human lifespan through early-stage venture investments. Its thesis targets the biology of aging across therapeutic development, diagnostic platforms, and AI-enabled drug discovery. This pure-play approach means it does not diversify into general biotech or healthtech sectors outside the longevity umbrella.
Does Longevity Venture Partners lead rounds or participate as a co-investor?
The firm's participation posture is not publicly confirmed. Early-stage longevity vehicles of similar size often prefer co-investment or syndicate participation alongside larger biotech funds. Without direct disclosure, the firm's lead-investor appetite remains unverified.
Which sectors does Longevity Venture Partners explicitly avoid?
By structural design, the firm avoids any sector outside the longevity economy. This excludes general biotechnology, medical devices not directly tied to aging mechanisms, late-stage pharmaceuticals, and health IT platforms without a geroscience or lifespan-extension component.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: